Reasons why guideline recommendations for anticoagulants should not be extended to patients with ‘resolved atrial fibrillation’

Anne Abbott

Research output: Contribution to journal › Letter › Other › peer-review

Original languageEnglish
JournalBMJ Open
Publication statusPublished - 22 May 2018

Cite this

Abbott, Anne. / Reasons why guideline recommendations for anticoagulants should not be extended to patients with ‘resolved atrial fibrillation’. In: BMJ Open. 2018.
@article{7435bc1ad3624270adbbaf383f6dc0a2,
title = "Reasons why guideline recommendations for anticoagulants should not be extended to patients with ‘resolved atrial fibrillation’",
author = "Anne Abbott",
year = "2018",
month = "5",
day = "22",
language = "English",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",

}

Abbott, A 2018, 'Reasons why guideline recommendations for anticoagulants should not be extended to patients with ‘resolved atrial fibrillation’' BMJ Open.

Reasons why guideline recommendations for anticoagulants should not be extended to patients with ‘resolved atrial fibrillation’. / Abbott, Anne.

In: BMJ Open, 22.05.2018.

Research output: Contribution to journal › Letter › Other › peer-review

TY - JOUR

T1 - Reasons why guideline recommendations for anticoagulants should not be extended to patients with ‘resolved atrial fibrillation’

AU - Abbott, Anne

PY - 2018/5/22

Y1 - 2018/5/22

M3 - Letter

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

ER -

Abbott A. Reasons why guideline recommendations for anticoagulants should not be extended to patients with ‘resolved atrial fibrillation’. BMJ Open. 2018 May 22.

Access to Document